ArticleNature computational science2026
De novo design of functional nucleic acids of aptamers.
Article in Nature computational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- SELEX-Based Aptamer Technologies for Toxin Analysis: Screening, Optimization, and Computational Assisted Design.Toxins · 2026Review
- Multivalent Aptamers: Contemporary Engineering Strategies and Biomedical Applications.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- De novo design of functional nucleic acids of aptamers.Nature computational science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Functional nucleic acids (FNAs) are essential elements for designing advanced molecular tools, yet their de novo design faces challenges due to the vast sequence space and inefficiency of experimental screening methods. Nucleic acid large language models (NA-LLMs) offer new opportunities for FNA design, but their generative capability remains underexplored. Here we introduce InstructNA, a framework leveraging NA-LLMs and high-throughput systematic evolution of ligands by exponential enrichment (HT-SELEX) to guide de novo design of FNAs without relying on structural information. InstructNA encodes semantically rich FNA representations and robustly decodes FNA sequences, enabling the generation of various types of FNA such as transcription factor-binding DNA and protein-binding aptamers with enhanced functionality and high sequence diversity. Compared with the traditional HT-SELEX, InstructNA generates 100% and 200% more strong aptamer binders for two protein targets, with a sequence similarity to the original HT-SELEX aptamers as low as 38%. These results underscore the efficacy and robustness of InstructNA, demonstrating its potential for FNA design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.